KYN is secreted by tumor cells and is further described to serve as a ligand for the cytoplasmic AhR of CD8+ T-cells, thereby inducing PD-1 expression and immune surveillance (Liu et al. 2018). The gene discussed is CD8A; the disease is neoplasm.